Search research articles
Contact Us
Filters
Showing results (41-50 of 129) with videos related to
Page
of 13
Sort By:
La Revue Du Praticien
|
December 5, 2018
Contraception
Geneviève Plu-Bureau, Lorraine Maitrot-Mantelet, Justine Hugon-Rodin, et al.
International Immunopharmacology
|
December 20, 2019
Exogenous hormones and hereditary angioedema
Anne Gompel, Olivier Fain, Isabelle Boccon-Gibod, et al.
La Revue Du Praticien
|
December 5, 2018
Contraception and risk of venous thromboembolism
Geneviève Plu-Bureau, Lorraine Maitrot-Mantelet, Justine Hugon-Rodin, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 4, 2011
Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis
Zeina Chakhtoura, Marianne Canonico, Anne Gompel, et al.
Breast Cancer Research and Treatment
|
August 6, 2011
Glucocorticoid receptor and breast cancer
Myriam Vilasco, Laudine Communal, Najat Mourra, et al.
Biochimie
|
May 25, 2011
The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers
Sandra Dupouy, Najat Mourra, Van Kien Doan, et al.
Presse Medicale (Paris, France : 1983)
|
May 4, 2015
[Hereditary angiœdema treatments: Recommendations from the French national center for angiœdema (Bordeaux consensus 2014)]
Laurence Bouillet, Audrey Lehmann, Anne Gompel, et al.
Journal of the Endocrine Society
|
December 22, 2017
Combined Hormonal Contraceptives and First Venous Thrombosis in Young French Women: Impact of Thrombotic Family History
Justine Hugon-Rodin, Marie-Hélène Horellou, Jacqueline Conard, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 23, 2009
Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition
Emile Petit, Aurélie Courtin, Helenius J Kloosterboer, et al.
Thrombosis and Haemostasis
|
April 4, 2018
Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism
Justine Hugon-Rodin, Marie-Hélène Horellou, Jacqueline Conard, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 129) with videos related to
Sort By:
Page
of 13
La Revue Du Praticien
|
December 5, 2018
Contraception
Geneviève Plu-Bureau, Lorraine Maitrot-Mantelet, Justine Hugon-Rodin, et al.
International Immunopharmacology
|
December 20, 2019
Exogenous hormones and hereditary angioedema
Anne Gompel, Olivier Fain, Isabelle Boccon-Gibod, et al.
La Revue Du Praticien
|
December 5, 2018
Contraception and risk of venous thromboembolism
Geneviève Plu-Bureau, Lorraine Maitrot-Mantelet, Justine Hugon-Rodin, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 4, 2011
Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis
Zeina Chakhtoura, Marianne Canonico, Anne Gompel, et al.
Breast Cancer Research and Treatment
|
August 6, 2011
Glucocorticoid receptor and breast cancer
Myriam Vilasco, Laudine Communal, Najat Mourra, et al.
Biochimie
|
May 25, 2011
The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers
Sandra Dupouy, Najat Mourra, Van Kien Doan, et al.
Presse Medicale (Paris, France : 1983)
|
May 4, 2015
[Hereditary angiœdema treatments: Recommendations from the French national center for angiœdema (Bordeaux consensus 2014)]
Laurence Bouillet, Audrey Lehmann, Anne Gompel, et al.
Journal of the Endocrine Society
|
December 22, 2017
Combined Hormonal Contraceptives and First Venous Thrombosis in Young French Women: Impact of Thrombotic Family History
Justine Hugon-Rodin, Marie-Hélène Horellou, Jacqueline Conard, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
April 23, 2009
Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition
Emile Petit, Aurélie Courtin, Helenius J Kloosterboer, et al.
Thrombosis and Haemostasis
|
April 4, 2018
Type of Combined Contraceptives, Factor V Leiden Mutation and Risk of Venous Thromboembolism
Justine Hugon-Rodin, Marie-Hélène Horellou, Jacqueline Conard, et al.
Page
of 13